Stevens Emily, Kimler Bruce F, Davis Marilyn K, Fan Fang, Thomas Patricia, Wang Xiao-Yun, Damjanov Ivan, Tawfik Ossama W
Pathology and Laboratory Medicine Department, University of Kansas Medical Center, Kansas City, Kansas 66160, USA.
Ann Clin Lab Sci. 2009 Winter;39(1):25-31.
Invasive ductal carcinoma (IDC) of the breast is currently graded according to the Nottingham modification of the Scarff-Bloom-Richardson system (SBR). This system involves subjective evaluation of 3 morphologic features: tubule formation, nuclear pleomorphism, and mitosis. Our recently proposed semi-automated Nuclear and Proliferation Index [N+P] grading system for IDC has demonstrated agreement among grades and prognostic markers with better prediction of patient survival than the SBR system. Our present objective is to expand the utilization of the N+P system to grading invasive lobular carcinoma (ILC). Fifty-eight ILC cases were evaluated by the SBR and N+P systems. The 2 systems were compared in terms of correlation with patient survival, tumor size, grade, angiolymphatic invasion, lymph node status, ploidy status, and ER, PR, Her-2, p53, EGFR, and Bcl-2 staining. The N+P and SBR systems demonstrated overall agreement when correlated with clinical and prognostic parameters. Twenty-four of 30 tumors initially classified as SBR Grade II were down-graded to N+P I. Three of 26 tumors initially classified as SBR Grade I were up-graded to N+P II. Grading of ILC provides valuable predictive and prognostic information. The N+P grading system for ILC decreases the element of subjectivity for assessing mitotic activity and appears to be superior to the SBR system in predicting patient survival.
乳腺浸润性导管癌(IDC)目前根据斯卡夫-布鲁姆-理查森系统(SBR)的诺丁汉改良版进行分级。该系统涉及对3种形态学特征的主观评估:小管形成、核异型性和有丝分裂。我们最近提出的用于IDC的半自动核与增殖指数[N+P]分级系统已证明在分级和预后标志物方面具有一致性,并且在预测患者生存方面比SBR系统表现更好。我们目前的目标是将N+P系统的应用扩展到浸润性小叶癌(ILC)的分级。通过SBR和N+P系统对58例ILC病例进行了评估。比较了这两种系统在与患者生存、肿瘤大小、分级、血管淋巴管浸润、淋巴结状态、倍体状态以及雌激素受体(ER)、孕激素受体(PR)、人表皮生长因子受体2(Her-2)、p53、表皮生长因子受体(EGFR)和Bcl-2染色的相关性方面的差异。当与临床和预后参数相关联时,N+P和SBR系统总体上具有一致性。最初分类为SBR II级的30个肿瘤中有24个被下调为N+P I级。最初分类为SBR I级的26个肿瘤中有3个被上调为N+P II级。ILC的分级提供了有价值的预测和预后信息。用于ILC的N+P分级系统减少了评估有丝分裂活性时的主观性因素,并且在预测患者生存方面似乎优于SBR系统。